Mirvaso (brimonidine) Topical Gel, 0.33%, 30 g (RX)

Favorites 3 favorites

How safe is it?

Product Description

MIRVASO® (brimonidine) topical gel, 0.33% is the first and only FDA-approved treatment developed and indicated for persistent (nontransient) facial redness of rosacea. Facial redness is a common symptom of rosacea, a skin condition that affects an estimated 16 million Americans

MIRVASO Gel is a temporary treatment for facial redness
MIRVASO Gel may dramatically reduce your symptoms, but it won't prevent or cure facial redness. Your redness will return after the effect of MIRVASO Gel wears off.

Ingredients (9)

Popular Ingredients In This Product
All Ingredients
Legal Disclaimer - Actual product packaging and materials may contain more and different product and ingredient information than what is shown on our website. We recommend that you do not rely solely on the information presented and that you always read labels, warnings, and directions before using or consuming a product.
Loader wave
Hang tight. We're thinking.